News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Staff/Faculty Update
Goodman appointed to City of St. Louis Board of Health and Hospitals
Melody Goodman, PhD, an assistant professor of surgery at Washington University School of Medicine and a research member of Siteman Cancer Center, has been appointed to the City of St. Louis Board of Health and Hospitals. Mayor Francis Slay appointed Goodman, who will serve until 2019. In the role, she will advise the city health […]
Research
Some deadly breast cancers share genetic features with ovarian tumors
The most comprehensive analysis yet of breast cancer shows that one of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers. The findings, published online Sept. 23 in Nature, suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with […]
Research
Special glasses help surgeons ‘see’ cancer
High-tech glasses developed at Washington University School of Medicine in St. Louis may help surgeons visualize cancer cells, which glow blue when viewed through the eyewear. The wearable technology, so new it’s yet unnamed, was used during surgery for the first time Feb. 10, 2014 at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School […]
Clinical, Research
Breast cancer vaccine shows promise in small clinical trial
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression. The study appears Dec. 1 […]
In the Media
Personalized melanoma vaccines marshal powerful immune response
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. The tailor-made vaccines, given to three patients with advanced melanoma, appeared to increase the number and diversity of cancer-fighting […]
In the Media
Mardis Elected to AACR Board of Directors
Elaine Mardis, PhD, the Robert E. and Louise F. Dunn Distinguished Professor of Medicine, has been elected to the board of directors of the American Association for Cancer Research (AACR). Mardis, a professor of molecular microbiology and of genetics and co-director of The Elizabeth H. and James S. McDonnell III Genome Institute, will begin her […]
In the Media
Kidney Cancer Detected Early With Urine Test
If kidney cancer is diagnosed early — before it spreads — 80 percent of patients survive. However, finding it early has been among the disease’s greatest challenges. Now, researchers at Washington University School of Medicine in St. Louis have developed a noninvasive method to screen for kidney cancer that involves measuring the presence of proteins […]
In the Media
Innovative Light Therapy Reaches Deep Tumors
Light long has been used to treat cancer. But phototherapy is only effective where light easily can reach, limiting its use to cancers of the skin and in areas accessible with an endoscope, such as the gastrointestinal tract. Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis and […]
In the Media
Preventing early-onset colorectal cancers aim of $25 million award
School of Medicine leads international team funded by Cancer Grand Challenges Colorectal cancer rates in adults under age 50 have been increasing in the U.S. and globally. The risk of developing such cancers has been rising with each generation since the 1950s, but scientists have not been able to explain why. Understanding the underlying causes […]
Research
$2.1 million in cancer research grants awarded by Siteman Investment Program
Research on colon cancer, breast cancer and acute myeloid leukemia are among the seven projects that will benefit from $2.1 million in new grants announced by Siteman Cancer Center through its Siteman Investment Program. The goal of the grants is to support and accelerate the pace of innovation in cancer research. The money awarded comes from a variety of sources: Pedal […]